More energy, please! For cryin' out loud, we had no fewer than THREE DEALS emerging today and what happens, The Street yawns, we drift lower.
Since the start of the year, the Dow has last a quarter of its value. And with even with today's late gain, pockets of optimism are hard to find. Having said that, there were some positive signs in the options market this week, which predicted much of the pain were in right now.
Dow Chemical and Rohm & Haas are in "longshot talks" to settle their dispute over Dow's stalled takeover of Rohm, CNBC learned, citing sources familiar with the situation.
Dow Chemical and Rohm & Haas, which will face off in a Delaware court next Monday to determine Dow's $78 cash deal to acquire Rohm & Haas, are engaged in talks to find a resolution to their dispute, CNBC has learned.
Stocks opened the new week lower, and continued to slide. That's the bad news. What could the good news be? A down market is where values are created, and Mary Jane Matts and Mark Travis say they've pinpointed some good targets for the savvy investor. (Part One)
Dow Chemical faces daunting legal and business challenges but is nonetheless raising bullish speculation among options traders.
Plus, Cramer extends an invitation to Pepsi’s Indra Nooyi, talks technicals and makes a call on Dow Chemical.
Cramer makes the call on viewers' favorite stocks.
Sentence/Paragraph
Talk about a busy day: we have Mr. Bernanke testifying, Treasury Secretary Geithner speaking, the Senate voting on the stimulus bill, and a huge Treasury auction at 1 PM.
Dow Chemical is seeing strong call activity despite a posting a weak earnings report yesterday. Early Thursday, traders bought some 10,700 calls at the February 12.40 strike, which quickly rose in price from $0.20 to $0.35. Many of those calls (DOWBV) were bought in blocks as large as 2,448 contracts each
As market participants anticipate possible stagnant growth in the coming quarters, investors might be more apt to get back to "old fashioned" investing with higher-yielding stocks.
Stocks ended higher Tuesday, snapping a three-day losing streak, as an earnings beat from Merck and better-than-expected housing report gave the market a boost.
Once again, a midday drop in the dollar has led to a (modest) rally in stocks. This happened yesterday. Traders are not stupid (they're just poor).
Stocks had a topsy-turvy morning as investors digested a revival in pending-home sales and an earnings beat from Merck against some gloomy news out of the tech sector.
Overseas markets are mixed this morning. Australia cut its interest rates to a record low 3.25 percent and unveiled a stimulus plan, while the Bank of Japan said it would buy up to $11 billion of shares held by banks.